OUR TEAM

Laura Chubb

Partner

Laura Chubb

Partner

Laura’s experience in many facets of strategic intellectual property counseling gives her a deep knowledge base for understanding her clients’ needs and advising them.
Laura’s experience in many facets of strategic intellectual property counseling gives her a deep knowledge base for understanding her clients’ needs and advising them.

OVERVIEW

Laura Chubb is an intellectual property partner in the firm’s New York office whose practice focuses on patent litigation, related complex commercial disputes, and strategic patent counseling for pharmaceutical and biotechnology companies in the life sciences industry. Laura has experience across a wide range of technologies, including pharmaceuticals, chemicals, and biotechnology. Laura litigates across the country, and provides multi-jurisdictional and global strategy and advice from case inception through resolution. Laura also counsels clients on patent strategy, including pre-litigation activities, freedom-to-operate analysis, portfolio management, and due diligence. Laura has a degree in molecular biology and is admitted to practice before the United States Patent and Trademark Office.

Laura also has experience in global trademark procurement and protection, including oppositions and district court actions.

Laura is active in the legal community. She was designated by the firm as a 2022 Fellow in the Leadership Council on Legal Diversity, and was nominated by the firm to participate in the 2017-18 Federal Circuit Bar Association’s Global Fellows Program. She co-chairs the Trade Secret Committee of the New York Intellectual Property Law Association.

In law school, Laura graduated cum laude and was the Executive Production Editor of the Indiana International and Comparative Law Review.

REPRESENTATIVE PATENT CASES

  • Rigshospitalet v. Shire-NPS Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc., No. 1:21cv11602 (D.Mass.) – patent inventorship and contract dispute concerning method of using peptide drug
  • RSA Protective Technologies, LLC v. Delta Scientific Corp., No. 2:19cv06024 (C.D. Cal.) – patent litigation concerning security bollards where successfully excluded opposing party’s damages expert
  • Massachusetts Institute of Technology et al v. Shire Pharmaceuticals, Inc., No. 1:13cv10020 (D.Mass.) – damages phase of patent litigation concerning dermal substitute
  • Shire Development LLC et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 1:17cv01696 (D.Del.) – Hatch-Waxman litigation concerning small molecule extended-release drug
  • Shire Orphan Therapies LLC et al v. Fresenius Kabi USA, LLC, No. 1:15cv01102 (D.Del.) – Hatch-Waxman litigation concerning decapeptide drug where successfully enjoined generic drug manufacturer following trial
  • Supernus Pharmaceuticals, Inc. v. TWI Pharmaceuticals, Inc. et al, No. 1:15cv00369 (D.N.J.) – patent litigation concerning small molecule extended-release drug
  • Supernus Pharmaceuticals, Inc. v. Actavis Inc. et al, No. 1:13cv04740 (D.N.J.) – patent litigation concerning small molecule extended-release drug
  • Microbix Biosystems, Inc. v. Novartis Vaccines and Diagnostics, Inc., No. 6:14cv00003 (E.D.Tex.) – patent litigation concerning vaccine manufacturing process
  • Somanetics Corp. v. CAS Medical Systems, Inc., No. 2:09-cv-13110 (E.D.Mich.) – patent litigation concerning cerebral oximeter
  • Higher One Inc v. Touchnet Info Sys Inc, No. 3:09cv00337 (D.Conn.) – patent litigation concerning business method software
  • Medical Research Institute v. Bio-Engineered Supplements & Nutrition Inc et al, No. 6:05cv00417 (E.D.Tex.) – patent litigation concerning dietary supplement composition
VIEW ALL

PUBLICATIONS

VIEW ALL

SPEAKING ENGAGEMENTS

  • “How Not to Destroy Your Trade Secrets,” Speaker, NYIPLA Fall Patent CLE Series, November 19, 2021.
  • “Exploring the New Patent Litigation Hotbeds After TC Heartland Reshaped the Map,” Speaker, Patent Law Institute 2021: Critical Issues & Best Practices, April 2, 2021.
  • “The Undisclosed Reality: The Rising Importance of Trade Secrets in IP Portfolios,” Moderator, NYIPLA Fall Patent CLE Series, Webinar, November 19, 2020.
  • “A Conversation with STEM Leaders,” Moderator, BioNJ Inspiring Women in STEM Conference, Bridgewater, New Jersey, December 1, 2017.
  • “Current Hot News in the IP Industry: Venue, Trade-Secrets and On-Sale Bar,” Speaker, New York Law Journal In-House CLE Seminar, The Yale Club of New York, May 20, 2016.
  • “Creating Your Legacy: A Pipeline for the Next Generation?” Moderator, NAWL Annual Meeting, New York, NY, July 16, 2015.
VIEW ALL

EDUCATION

  • Indiana University, Robert H. McKinney School of Law
  • Vanderbilt University (B.A., molecular biology)

BAR ADMISSIONS

  • New York
  • Illinois
  • Registered to practice before the U.S. Patent and Trademark Office
  • Court of Appeals for the Federal Circuit
  • Southern District of New York
  • Western District of New York
  • Eastern District of New York
  • Eastern District of Texas
  • District of Connecticut
  • Northern District of Illinois
  • Eastern District of Michigan
VIEW ALL

MEMBERSHIPS

  • Leadership Counsel on Legal Diversity, 2022 Fellow
  • New York Intellectual Property Law Association, Co-Chair of Trade Secret Committee and Member of Women in IP Committee
  • Federal Circuit Bar Association, 2017-2018 Global Fellow
  • ChIPs, Member
  • WIN: The Women in IP Network, Member
VIEW ALL

CONTACT

LOCATION

New York City
745 5th Avenue Floor 10 
New York, NY 10151
745 5th Avenue Floor 10 New York, NY 10151